Deepti Gurdasani

Last updated

Deepti Gurdasani
Alma mater University of Cambridge
Christian Medical College Vellore
Scientific career
Institutions Queen Mary University of London
Wellcome Sanger Institute
Thesis Design strategies in the study of genetics of complex disease in diverse populations.  (2014)
Website www.qmul.ac.uk/whri/people/academic-staff/items/gurdasanideepti.html

Deepti Gurdasani is a British-Indian clinical epidemiologist and statistical geneticist who is a senior lecturer in machine learning at the Queen Mary University of London. [1] Her research considers the genetic diversity of African Populations. Throughout the COVID-19 pandemic, Gurdasani has provided the public with her analysis of the evolving situation mainly on the Twitter platform.

Contents

Early life and education

Gurdasani was an undergraduate student at the Christian Medical College Vellore, where she studied medicine. After earning her medical degree she moved to the United Kingdom, where she worked toward a doctorate at the University of Cambridge. Her doctoral research involved the design of strategies to understand complex diseases in diverse populations. [2]

Research and career

In 2013, Gurdasani joined the Wellcome Sanger Institute as a postdoctoral fellow, [3] [4] where she worked on the genomic diversity of African populations and how this diversity impacts susceptibility to disease. She makes use of dense genotypes and whole genome sequences to better understand how population movements determined genetic structure. In particular, Gurdasani develops machine learning algorithms to large-scale clinical data sets. [5] At the Sanger Gurdasani co-led the African Genome Variation Project and the Uganda Resource Project. [5]

Gurdasani moved to Queen Mary University of London in 2019, where she created deep learning approaches for clinical prediction and the identification of novel, genome-based drug targets. During the COVID-19 pandemic Gurdasani has provided public commentary on the pandemic, making use of both Twitter and print media to share information on the evolving situation. [1] She has researched the incidence of long covid in the UK. [6] In 2021 Gurdasani started to write for The Guardian . [1]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Wellcome Trust</span> British healthcare research charity established in 1936

The Wellcome Trust is a charitable foundation focused on health research based in London, United Kingdom. It was established in 1936 with legacies from the pharmaceutical magnate Henry Wellcome to fund research to improve human and animal health. The aim of the Trust is to "support science to solve the urgent health challenges facing everyone." It had a financial endowment of £29.1 billion in 2020, making it the fourth wealthiest charitable foundation in the world. In 2012, the Wellcome Trust was described by the Financial Times as the United Kingdom's largest provider of non-governmental funding for scientific research, and one of the largest providers in the world. According to their annual report, the Wellcome Trust spent GBP £1.1 billion on charitable activities across their 2019/2020 financial year. According to the OECD, the Wellcome Trust's financing for 2019 development increased by 22% to US$327 million.

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

DECIPHER is a web-based resource and database of genomic variation data from analysis of patient DNA. It documents submicroscopic chromosome abnormalities and pathogenic sequence variants, from over 25000 patients and maps them to the human genome using Ensembl or UCSC Genome Browser. In addition it catalogues the clinical characteristics from each patient and maintains a database of microdeletion/duplication syndromes, together with links to relevant scientific reports and support groups.

<span class="mw-page-title-main">Jeremy Farrar</span> British medical researcher

Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.

Mitali Mukerji is a Professor and Head of the Department of Bioscience and Bioengineering, IIT Jodhpur. She was formerly a Chief Scientist at the CSIR Institute of Genomics and Integrative Biology with notable achievement in the field of human genomics and personalized medicine. She is best known for initiating the field of "Ayurgenomics" in partnership with her colleague Dr. Bhavana Prasher under the mentorship of Prof. Samir K. Brahmachari. Ayurgenomics is an innovative study, blending the principles of Ayurveda- the traditional Indian system of medicine- with genomics. Mukerji is also a major contributor in the Indian Genome Variation Consortium, a comprehensive database that is producing "the first genetic landscape of the Indian population", and has been an author in many publications that use IGV databases to study population genomics. Mukerji has done extensive research on hereditary ataxias, and is involved in many other projects related to tracking disease origins and mutational histories. She is the recipient of the prestigious Shanti Swarup Bhatnagar Award in 2010 for her contribution in the field of Medical Sciences.

The 100,000 Genomes Project is a now-completed UK Government project managed by Genomics England that is sequencing whole genomes from National Health Service patients. The project is focusing on rare diseases, some common types of cancer, and infectious diseases. Participants give consent for their genome data to be linked to information about their medical condition and health records. The medical and genomic data is shared with researchers to improve knowledge of the causes, treatment, and care of diseases. The project has received over £300 million from public and private investment.

Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge, and Master of Churchill College, Cambridge.

<span class="mw-page-title-main">Jonathan Marchini</span> Professor of Statistical Genomics

Jonathan Laurence Marchini is a Bayesian statistician and professor of statistical genomics in the Department of Statistics at the University of Oxford, a tutorial fellow in statistics at Somerville College, Oxford and a co-founder and director of Gensci Ltd. He co-leads the Haplotype Reference Consortium.

<span class="mw-page-title-main">Dominic Kwiatkowski</span> English medical researcher (1953–2023)

Dominic Kwiatkowski was an English medical researcher and geneticist who was head of the parasites and microbes programme at the Wellcome Sanger Institute in Cambridge and a Professor of Genomics at the University of Oxford. Kwiatkowski applied genomics and computational analysis to problems in infectious disease, with the aim of finding ways to reduce the burden of disease in the developing world.

<span class="mw-page-title-main">Nicole Soranzo</span> Italian British geneticist

Nicole Soranzo is an Italian-British senior group leader in human genetics at the Wellcome Sanger Institute, Professor of Human Genetics at the University of Cambridge. She is an internationally recognised Human Geneticist who has focused on the application of cutting edge genomic technologies to study the spectrum of human genetic variation associated with cardio-metabolic and immune diseases. She has led many large-scale discovery efforts including more than 1,000 novel genetic variants associated with cardio-metabolic diseases and their risk factors as well as establishing the HaemGen consortium, which is a worldwide effort to discover genetic determinants of blood cell formation and also interpretation of the downstream consequences of sequence variation through a host of integrative analyses and functional approaches.

Sarah Anne Tishkoff is an American geneticist and the David and Lyn Silfen Professor in the Department of Genetics and Biology at the University of Pennsylvania. She also serves as a director for the American Society of Human Genetics and is an associate editor at PLOS Genetics, G3, and Genome Research. She is also a member of the scientific advisory board at the David and Lucile Packard Foundation.

<span class="mw-page-title-main">Charles Rotimi</span> Nigerian geneticist

Charles Nohuoma Rotimi is the Scientific Director of the National Human Genome Research Institute (NHGRI). He joined the National Institutes of Health (NIH) in 2008 as the inaugural Director of the Trans-NIH Center for Research in Genomics and Global Health and was also the chief of the NHGRI's Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch. He works to ensure that population genetics include genomes from African populations and founded the African Society of Human Genetics in 2003 and was elected its first president. Rotimi was instrumental in the launch of the Human Heredity and Health in Africa (H3Africa) with the NIH and the Wellcome Trust. He was elected to the National Academy of Medicine in 2018.

<span class="mw-page-title-main">Devi Sridhar</span> Global public health researcher

Devi Lalita Sridhar FRSE is an American public health researcher, who is both professor and chair of global public health at the University of Edinburgh, Scotland. Her research considers the effectiveness of public health interventions and how to improve developmental assistance for health. Sridhar directs the University of Edinburgh's Global Health Governance Programme which she established in 2014.

<span class="mw-page-title-main">Christine Patch</span> Nurse and genetic counsellor

Christine Patch is a nurse and genetic counsellor. She is a Principal Staff Scientist in Genomic Counselling in the Society and Ethics Research group, part of Wellcome Connecting Science, based on the Wellcome Genome Campus. She is also the Clinical Lead for Genetic Counselling at Genomics England, and a former President of the European Society of Human Genetics.

Nisreen Ala-Din A. S. Alwan MBE is a British–Iraqi public health researcher who is a professor of Public Health at the University of Southampton. Her research considers maternal and child health. During the COVID-19 pandemic, Alwan used social media to communicate public health messages and to call for long covid to be counted and measured. In 2020, Alwan was selected as one of the BBC's top 100 Women.

<span class="mw-page-title-main">COVID-19 Genomics UK Consortium</span> British genomics research consortium

The COVID-19 Genomics UK (COG-UK) consortium was a group of academic institutions and public health agencies in the United Kingdom created in April 2020 to collect, sequence and analyse genomes of SARS-CoV-2 at scale, as part of COVID-19 pandemic response.

Serena Nik-Zainal is a British-Malaysian clinician who is a consultant in clinical genetics and Cancer Research UK advanced clinician scientist at the University of Cambridge. She makes use of genomics for clinical applications. She was awarded the Crick Lecture by the Royal Society in 2021. Serena Nik-Zainal was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.

Elizabeth Ashley is a British physician who is Director of the Laos-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) in Laos. She specialises in infectious diseases and medical microbiology and virology. She is an associate editor for the Malaria Journal and serves on the Council of the International Society for Infectious Diseases.

Debby Bogaert is a Dutch physician who is Professor of Paediatric Infectious Diseases at the University of Edinburgh. Her research considers the physiology and pathophysiology of respiratory infections.

Ambroise Wonkam is a Cameroonian medical doctor and professor of medical genetics at Johns Hopkins School of Medicine. His research is in sickle cell disease, the genetics of congenital hearing impairment, and ethics in human genetics. He is the current president of the African Society of Human Genetics.

References

  1. 1 2 3 "Deepti Gurdasani | The Guardian". the Guardian. Retrieved 5 July 2021.
  2. Gurdasani, Deepti; University of Cambridge (2014). Design strategies in the study of genetics of complex disease in diverse populations. OCLC   1063777668.
  3. "Gurdasani, Deepti – Wellcome Sanger Institute". www.sanger.ac.uk. Retrieved 5 July 2021.
  4. "Dr Deepti Gurdasani". HDR UK. Retrieved 5 July 2021.
  5. 1 2 "Gurdasani, Deepti – The William Harvey Research Institute – Barts and The London". www.qmul.ac.uk. Retrieved 5 July 2021.
  6. "'Long Covid' affecting significant numbers, says Dr Deepti Gurdasani". BBC. 21 June 2021. Retrieved 12 July 2021.